Nexus Pharmaceuticals
Riemon Anwiya, M.S., is an accomplished analytical scientist currently serving as the Lead Analytical Scientist at Nexus Pharmaceuticals, Inc. since December 2020. Prior experience includes a role as an Analytical Scientist at Wockhardt USA from July 2013 to September 2020, as well as a Graduate Assistant position at Northeastern Illinois University from August 2012 to June 2013. Riemon's foundational experience includes military service as a Sergeant of Marines in the U.S. Marine Corps from September 1999 to September 2003. Educational qualifications consist of a Master of Science in Separation Chemistry from Northeastern Illinois University, a Bachelor of Science in Biological Sciences, and a Bachelor of Arts in Chemistry from the University of Illinois Chicago, along with an Associate of Arts in General Studies from Central Texas College.
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow